Background
Quanta Dialysis Technologies makes dialysis more affordable and more convenient for the nearly 2 million patients who are impacted by end stage kidney disease. The cost and inconvenience of hospital hemodialysis treatment is a major barrier to health care access for these patients. A year of hospital hemodialysis costs on average $88,585 per patient year. Plus, because hemodialysis centers aren’t often open on weekends, patients have 23% increased risk of dying and an 8X chance of ending up in the emergency room on Mondays, a phenomenon referred to as “Monday Morning Mortality.”
With portable in-home dialysis units, in-home treatment costs drop to an average of $32,570 per patient per year. In addition, patients don’t have the hassle and expense – or risk secondary health exposures – by going into a medical setting. Quanta’s dialysis console system has been FDA-cleared for use in chronic and acute care settings.
Since catching the eye of many investors and winning more than 6 prestigious awards, Quanta has attracted over £246 million in venture capital funding. This propelled them into the marketplace. However, with many challenges looming in their path for mass production, distribution, and 24/7 customer care, many voices competed for funding, one of which was a total rehaul of the IT system infrastructure. With more than 40 major system touchpoints, 23 different systems, and minimal integrations, a new ERP system was a must.
Since Quanta determined that their existing fragment systems were not sufficient to meet their market demands in the UK and US, they spent many months researching various ERP providers. Being in the world of medical devices, first-rate technology was a necessity for long term growth. Microsoft's cutting-edge technology and One Microsoft roadmap appealed to Quanta executives and was a key factor in selecting Dynamics 365 Finance and Supply Change software suite.
